1 Patterns of Drug Use: Methodological Considerations, Measurement Techniques, and Future Trends.- 2 Litigation and the Use of Psychoactive Drugs in Developmental Disabilities.- 3 Psychotropic Drug Blood Levels: Measurement and Relation to Behavioral Outcome in Mentally Retarded Persons.- 4 Neuroleptic Medications for Persons with Developmental Disabilities.- 5 Antiepileptic Drugs.- 6 Other Psychotropic Drugs.- 7 Novel Psychoactive Agents in the Treatment of Developmental Disorders.- 8 Vitamin, Mineral, and Dietary Treatments.- 9 Tardive Dyskinesia and Developmental Disabilities.- 10 Issues in Behavioral Pharmacology: Implications for Developmental Disorders.- 11 Conclusions.- Glossary of Psychotropic Drug Classes, Generic Names, and Trade Names.- Author Index.
Psychopharmacology of the Developmental Disabilities explores the use of psychotropic and antiepileptic medications in developmentally disabled patients. A distinguished group of international experts offers comprehensive coverage of traditional psychotropic as well as novel pharmacological agents, antiepileptic drugs, and diet and vitamin treatments. Issues related to litigation, measurement of blood levels, tardive dyskinesia, and behavioral pharmacology are discussed in detail. Psychopharmacology of the Developmental Disabilities provides an excellent overview of what is known about psychoactive drugs and an awareness of the principal social and medical issues posed by these agents.
Springer Book Archives